To test our hypothesis that post-treatment T cells represent a re-expansion of prior T cell responses, we purified SIY-specific pentamer binding CD8 T cells at day 7 following tumor implantation, and again at d21 following combined therapy (Fig. 6ci). This evidence concerns the gene CD8A and neoplasm.